Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers

Sponsor
Dr.Pankaj Chaturvedi (Other)
Overall Status
Recruiting
CT.gov ID
NCT04809324
Collaborator
(none)
1,206
3
2
78.5
402
5.1

Study Details

Study Description

Brief Summary

Surgical margin is a significant prognostic factor in oral cavity squamous cell carcinoma (OCSCC)[1,2,3]. Intra-operative frozen section (FS) has been routinely used by the surgeons to achieve adequate surgical margins. However published literature has failed to show a conclusive benefit of FS in improving oncological outcomes(4-7). The overall identification rate of the inadequate margins by FS is variable with figures in the literature ranging from25-34%.(8-10)

Revision of margins based on FS is widely practiced in centers where facility for FS is available. However this has not shown to significantly improve local control when compared to cases in which FS was not utilized , in a comparative study done at Tata memorial Hospital(TMH) (5) More-over FS is a costly procedure, and sparsely available in resource- poor countries. In a recently conducted retrospective study of 1237 patients conducted at TMH, the cost benefit ratio of FS for assessment of margin is as low as 12:1(11). In another prospective study performed at the same center , investigators found that gross examination (GE) of margins by the surgeons was as effective as FS, and achievement of gross 7mm margin all around the tumor obviated the need for FS (12). In a recent meta-analysis of 8 studies that looked at the utility of frozen section and had uniformity in frozen section analysis and definition of close margins, they concluded that revision of margins based on FS does not improve oncological outcomes and further prospective studies are needed to explore this contentious issue (13). With this background, a prospective RCT is planned to explore if gross examination by surgeon and subsequent revision of margin (if necessary) is an equally effective alternative to Frozen section based revision in a randomized controlled trial.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Gross examination of the resection specimen
  • Procedure: Frozen section
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1206 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Masking Description:
patient and the treating clinician will not be aware of the randomisation allocation(gross examination or frozen section) prior to resection of the tumour specimen
Primary Purpose:
Treatment
Official Title:
Intra-operative Gross Examination Versus Frozen Section for Achievement of Adequate Margin in Patients Undergoing Surgery for Oral Cavity Squamous Cell Carcinoma: A Randomized Controlled Trial
Actual Study Start Date :
Nov 15, 2021
Anticipated Primary Completion Date :
Dec 1, 2026
Anticipated Study Completion Date :
Jun 1, 2028

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gross examination

measurement of the surgical margins will be done by the surgeon in the operating room using sterile scale after resection of the primary tumor .

Procedure: Gross examination of the resection specimen
measurement of the surgical margin by the operating surgeon using sterile scale, margins <7mm will be revised on table

Active Comparator: Frozen section

frozen section examination of surgical margins will be done by the pathologist.

Procedure: Frozen section
frozen section evaluation of the specimen by the pathologist

Outcome Measures

Primary Outcome Measures

  1. local recurrence free survival (LRFS) between two arms [2 years]

    To determine the difference between the local recurrence free survival (LRFS) between intra operative gross examination by the surgeon compared with microscopic examination using frozen sections by the pathologist for the assessment of surgical margin in patients undergoing surgery for OCSCC. Local recurrence will be defined as - tumor recurrence at the same subsite or or at margins of previous surgery &/ reconstruction with or without nodal recurrence /distant metastases withing two years after completion of the treatment. - Isolated regional &/or distant metastasis without recurrence at local site will be recorded however it will not be considered as the event for measuring LRFS

Secondary Outcome Measures

  1. Accuracy of gross examination [5 years]

    To determine the accuracy of intra operative gross examination by the surgeon compared with microscopic examination of frozen sections by the pathologist for the assessment of surgical margin as compared to the final histopathology report as the gold standard.

  2. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of GE and FS for the assessment of surgical margin [5years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Biopsy proven treatment naïve cases of OCSCC who are planned for curative surgery with en-bloc removal of the tumor with adequate margin

  2. In detail assessment of the primary tumor is possible pre-operatively

  3. Written informed consent

  4. Age more than 18 years

Exclusion Criteria:
  1. Multifocal disease

  2. Clinically evident field cancerization

  3. Previous treatment for oral cavity cancer - Surgery /chemo or radiotherapy -

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tata Memorial Hospital Mumbai Maharashtra India 400012
2 ACTREC,Advanced Centre for Treatment, Research and Education in Cancer Navi Mumbai Raigad India -410210
3 Mahamana Pandit Madan Mohan Malaviya Cancer Centre Varanasi Uttar Pradesh India 221005

Sponsors and Collaborators

  • Dr.Pankaj Chaturvedi

Investigators

  • Principal Investigator: Pankaj Chaturvedi, MS, Tata Memorial Centre

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr.Pankaj Chaturvedi, Dr Pankaj Chaturvedi ,Prof. and Surgeon, Dept of Head Neck Surgery, Tata Memorial Centre
ClinicalTrials.gov Identifier:
NCT04809324
Other Study ID Numbers:
  • protocol no 3541
  • CTRI/2021/03/032015
First Posted:
Mar 22, 2021
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr.Pankaj Chaturvedi, Dr Pankaj Chaturvedi ,Prof. and Surgeon, Dept of Head Neck Surgery, Tata Memorial Centre
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2022